A widely-used chemotherapy drug used in cancer treatments could greatly increase patients’ long-term risk of hearing loss, according to a study by researchers at Indiana University and the University ...

A University of Sheffield researcher has uncovered new evidence that could help improve treatment options for patients with ...

During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer compared ...

Researchers at Brigham and Women’s Hospital developed a tool that predicts risks for moderate to severe kidney injury after treatment with the chemotherapy drug cisplatin. In a paper published in The ...

TAMPA, Fla. (June 28, 2024) --An interdisciplinary study led by researchers at the University of South Florida and Indiana University has uncovered significant findings on the long-term effects of one ...

Intermittent shortages of various injectable chemotherapy drugs have become a regular part of cancer care, with oncology practices reporting that despite their best efforts to mitigate supply ...

A beloved high school football coach died aged 60 due to a widespread shortage of a chemotherapy drug needed for his cancer treatment. Jeff Bolle was a force on the sports field as a varsity football ...

Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...

A new study tracked a cohort of testicular cancer survivors who received cisplatin-based chemotherapy for an average of 14 years, revealing that 78% experience significant difficulties in everyday ...